Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mellanox Technologies Ltd | NASDAQ:MLNX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 124.89 | 125.75 | 124.91 | 0 | 00:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 16, 2020
Mellanox Technologies, Ltd.
(Exact name of registrant as specified in its charter)
Israel |
001-33299 |
98-0233400 |
||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
Beit Mellanox
Yokneam, Israel
(Address of principal executive offices)
20692
(Zip Code)
+972-4-909-7200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class |
Trading Symbol |
Name of each exchange on which registered |
||
Ordinary Shares, nominal value NIS 0.0175 per share |
MLNX |
The Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. | Other Events. |
On April 16, 2020, Mellanox Technologies, Ltd. (“Mellanox”), and NVIDIA International Holdings Inc. (“NVIDIA Holdings”), received approval from the Anti-Monopoly Bureau of the State Administration for Market Regulation of the People’s Republic of China of the previously announced proposed acquisition of Mellanox by NVIDIA Holdings.
The two companies have now received regulatory antitrust approval for the deal from the European Commission, Mexico and China. In addition, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the proposed acquisition expired at 11:59 p.m., Eastern time, on May 23, 2019. The transaction is currently expected to close on or about April 27, 2020, subject to all remaining customary closing conditions.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 16, 2020 |
|
MELLANOX TECHNOLOGIES, LTD |
||||
|
|
By: |
/s/ Alinka Flaminia |
|||
|
|
Name: |
Alinka Flaminia |
|||
|
|
Title: |
SVP, General Counsel and Corporate Secretary |
1 Year Mellanox Technologies Chart |
1 Month Mellanox Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions